Pierre Gravier

CHIEF FINANCIAL OFFICER

Pierre Gravier (CHIEF FINANCIAL OFFICER) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in PTC Therapeutics, Inc. (PTCT). The largest single filing was $281K of PTCT (3,494 sh × $80.35, as filed), executed Jul 14.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$653K

shares × price, as filed

Last traded

Jul 14

Filed Jul 16

Median ADV $125.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $777K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

PTCT

PTC Therapeutics, Inc. PTCT · 0 buys · 4 sells 4 filings

Recent filings

PTCTSALE PTC Therapeutics, Inc. View filing → $281K
3,494 sh × $80.35
Exec Jul 14
Filed Jul 16 · 5:20 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $208K
2,992 sh × $69.36
Exec Feb 18
Filed Feb 20 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $165K
2,139 sh × $76.95
Exec Jan 6
Filed Jan 8 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $124K
2,516 sh × $49.46
Exec Jul 15 2025
Filed Jul 17 2025 · 5:30 PM ET